noscript

News and Announcements

$10 Million Institutional Placement to Drive OncoSil Commercialisation

  • Published February 03, 2016 2:41PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

3rd February 2016, ASX Announcement

OncoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to announce a A$10 million Institutional Placement (Placement) to drive commercialisation of the Company’s lead product candidate, the OncoSilTM localised radiation treatment for cancer.

The Placement is by way of Subscription Agreement for approximately 45,454,545 new Ordinary Shares in OncoSil Medical at a price of A$0.22 per share to raise $10 million.

The Company is delighted to receive this level of investment and financial backing at this point and time, and views it as strong validation for the OncoSilTM brachytherapy technology and its global commercialisation potential.

The Placement funds will be used to aggressively drive OncoSil Medical’s commercialisation plans to position OncoSilTM as an innovative, new medical radiation treatment for pancreatic cancer and other solid tumours – which have major un-met medical needs.

To read the full announcement, please click here

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now